Retrovirus gene therapy (Fred Hutchinson Cancer Research Center)

N/A

Report date: 2023/10/26 16:40:56

Base Information

Drug NameRetrovirus gene therapy (Fred Hutchinson Cancer Research Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDrug-Related Side Effects and Adverse Reactions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFred Hutchinson Cancer Research Center
Active IndicationsN/A
Inactive IndicationsDrug-Related Side Effects and Adverse Reactions

Other Information

ATC CodeN/A
Related LinksN/A